CHRIS W BODINE Insider Trading $AGN Allergan plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRIS W BODINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRIS W BODINE. CHRIS W BODINE is Executive Vice President in CVS HEALTH Corp ($CVS) and Director in Allergan plc ($AGN) and in OneWater Marine Inc. ($ONEW).
CHRIS W BODINE in Allergan plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRIS W BODINE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 11 2020
$AGN Market Capitalization: $87.25B
$AGN Previous Close: $234.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHRIS W BODINE in Allergan plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, CVS, ONEW
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2020 | AGN | Allergan plc | BODINE CHRIS W | Director | Sell | D | 0.00 | 18,615 | 0 | 0 | 18.6 K to 0 (-100.00 %) |
| May 11 2020 | AGN | Allergan plc | BODINE CHRIS W | Director | Sell | D | 0.00 | 18,615 | 0 | 0 | 18.6 K to 0 (-100.00 %) |
| May 04 2020 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 18,615 | 19.6 K to 18.6 K (-5.05 %) |
| May 04 2018 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 151.07 | 1,985 | 299,874 | 18,495 | 16.5 K to 18.5 K (+12.02 %) |
| May 03 2018 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 152.94 | 588 | 89,929 | 16,510 | 17.1 K to 16.5 K (-3.44 %) |
| Dec 07 2017 | AGN | Allergan plc | BODINE CHRIS W | Director | Buy | P | 164.77 | 3,030 | 499,253 | 17,098 | 14.1 K to 17.1 K (+21.54 %) |
| May 05 2017 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 245.25 | 1,223 | 299,941 | 14,068 | 12.8 K to 14.1 K (+9.52 %) |
| May 05 2017 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 12,845 | 13.5 K to 12.8 K (-4.94 %) |
| Aug 09 2016 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 248.31 | 201 | 49,910 | 14,279 | 14.1 K to 14.3 K (+1.43 %) |
| May 09 2016 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 210.34 | 1,188 | 249,884 | 14,078 | 12.9 K to 14.1 K (+9.22 %) |
| Aug 25 2015 | AGN | Allergan plc | BODINE CHRIS W | Director | Gift | G | 0.00 | 158 | 0 | 12,890 | 13 K to 12.9 K (-1.21 %) |
| Jun 08 2015 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 302.30 | 826 | 249,700 | 13,048 | 12.2 K to 13 K (+6.76 %) |
| Jun 08 2015 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 12,222 | 12.8 K to 12.2 K (-4.30 %) |
Page: 1